Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size, Status and Forecast 2024-2031

Report ID: 934287 | Published Date: May 2024 | No. of Page: 106 | Base Year: 2023 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 API Development
        1.2.3 Manufacturing
        1.2.4 Drug Delivery
    1.3 Market by Application
        1.3.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Pharmaceutical Company
        1.3.3 Biotechnology Company
        1.3.4 Generic Company
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Perspective (2016-2027)
    2.2 Bio Contract Development and Manufacturing Organizations (CDMOs) Growth Trends by Regions
        2.2.1 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Bio Contract Development and Manufacturing Organizations (CDMOs) Historic Market Share by Regions (2016-2021)
        2.2.3 Bio Contract Development and Manufacturing Organizations (CDMOs) Forecasted Market Size by Regions (2022-2027)
    2.3 Bio Contract Development and Manufacturing Organizations (CDMOs) Industry Dynamic
        2.3.1 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Trends
        2.3.2 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Drivers
        2.3.3 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Challenges
        2.3.4 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Bio Contract Development and Manufacturing Organizations (CDMOs) Players by Revenue
        3.1.1 Global Top Bio Contract Development and Manufacturing Organizations (CDMOs) Players by Revenue (2016-2021)
        3.1.2 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Players (2016-2021)
    3.2 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue
    3.4 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Concentration Ratio
        3.4.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue in 2020
    3.5 Bio Contract Development and Manufacturing Organizations (CDMOs) Key Players Head office and Area Served
    3.6 Key Players Bio Contract Development and Manufacturing Organizations (CDMOs) Product Solution and Service
    3.7 Date of Enter into Bio Contract Development and Manufacturing Organizations (CDMOs) Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Bio Contract Development and Manufacturing Organizations (CDMOs) Breakdown Data by Type
    4.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Historic Market Size by Type (2016-2021)
    4.2 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Forecasted Market Size by Type (2022-2027)

5 Bio Contract Development and Manufacturing Organizations (CDMOs) Breakdown Data by Application
    5.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Historic Market Size by Application (2016-2021)
    5.2 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size (2016-2027)
    6.2 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type
        6.2.1 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2021)
        6.2.2 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2022-2027)
        6.2.3 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2027)
    6.3 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application
        6.3.1 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2021)
        6.3.2 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2022-2027)
        6.3.3 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2027)
    6.4 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country
        6.4.1 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2016-2021)
        6.4.2 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size (2016-2027)
    7.2 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type
        7.2.1 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2021)
        7.2.2 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2022-2027)
        7.2.3 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2027)
    7.3 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application
        7.3.1 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2021)
        7.3.2 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2022-2027)
        7.3.3 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2027)
    7.4 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country
        7.4.1 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2016-2021)
        7.4.2 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size (2016-2027)
    8.2 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type
        8.2.1 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2027)
    8.3 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application
        8.3.1 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2027)
    8.4 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Region
        8.4.1 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size (2016-2027)
    9.2 Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type
        9.2.1 Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2021)
        9.2.2 Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2022-2027)
        9.2.3 Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2027)
    9.3 Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application
        9.3.1 Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2021)
        9.3.2 Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2022-2027)
        9.3.3 Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2027)
    9.4 Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country
        9.4.1 Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2016-2021)
        9.4.2 Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size (2016-2027)
    10.2 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type
        10.2.1 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2027)
    10.3 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application
        10.3.1 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2027)
    10.4 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country
        10.4.1 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Lonza
        11.1.1 Lonza Company Details
        11.1.2 Lonza Business Overview
        11.1.3 Lonza Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
        11.1.4 Lonza Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
        11.1.5 Lonza Recent Development
    11.2 Boehringer ‎Ingelheim
        11.2.1 Boehringer ‎Ingelheim Company Details
        11.2.2 Boehringer ‎Ingelheim Business Overview
        11.2.3 Boehringer ‎Ingelheim Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
        11.2.4 Boehringer ‎Ingelheim Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
        11.2.5 Boehringer ‎Ingelheim Recent Development
    11.3 Celltrion
        11.3.1 Celltrion Company Details
        11.3.2 Celltrion Business Overview
        11.3.3 Celltrion Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
        11.3.4 Celltrion Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
        11.3.5 Celltrion Recent Development
    11.4 Fujifilm
        11.4.1 Fujifilm Company Details
        11.4.2 Fujifilm Business Overview
        11.4.3 Fujifilm Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
        11.4.4 Fujifilm Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
        11.4.5 Fujifilm Recent Development
    11.5 Selexis
        11.5.1 Selexis Company Details
        11.5.2 Selexis Business Overview
        11.5.3 Selexis Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
        11.5.4 Selexis Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
        11.5.5 Selexis Recent Development
    11.6 Ology Bio
        11.6.1 Ology Bio Company Details
        11.6.2 Ology Bio Business Overview
        11.6.3 Ology Bio Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
        11.6.4 Ology Bio Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
        11.6.5 Ology Bio Recent Development
    11.7 Ardena
        11.7.1 Ardena Company Details
        11.7.2 Ardena Business Overview
        11.7.3 Ardena Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
        11.7.4 Ardena Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
        11.7.5 Ardena Recent Development
    11.8 Catalent
        11.8.1 Catalent Company Details
        11.8.2 Catalent Business Overview
        11.8.3 Catalent Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
        11.8.4 Catalent Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
        11.8.5 Catalent Recent Development
    11.9 AGC
        11.9.1 AGC Company Details
        11.9.2 AGC Business Overview
        11.9.3 AGC Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
        11.9.4 AGC Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
        11.9.5 AGC Recent Development
    11.10 Amgen
        11.10.1 Amgen Company Details
        11.10.2 Amgen Business Overview
        11.10.3 Amgen Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
        11.10.4 Amgen Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
        11.10.5 Amgen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of API Development
    Table 3. Key Players of Manufacturing
    Table 4. Key Players of Drug Delivery
    Table 5. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Regions (2016-2021)
    Table 9. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Regions (2022-2027)
    Table 11. Bio Contract Development and Manufacturing Organizations (CDMOs) Market Trends
    Table 12. Bio Contract Development and Manufacturing Organizations (CDMOs) Market Drivers
    Table 13. Bio Contract Development and Manufacturing Organizations (CDMOs) Market Challenges
    Table 14. Bio Contract Development and Manufacturing Organizations (CDMOs) Market Restraints
    Table 15. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Players (2016-2021)
    Table 17. Global Top Bio Contract Development and Manufacturing Organizations (CDMOs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) as of 2020)
    Table 18. Ranking of Global Top Bio Contract Development and Manufacturing Organizations (CDMOs) Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Bio Contract Development and Manufacturing Organizations (CDMOs) Product Solution and Service
    Table 22. Date of Enter into Bio Contract Development and Manufacturing Organizations (CDMOs) Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Type (2016-2021)
    Table 26. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Application (2016-2021)
    Table 30. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Lonza Company Details
    Table 63. Lonza Business Overview
    Table 64. Lonza Bio Contract Development and Manufacturing Organizations (CDMOs) Product
    Table 65. Lonza Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021) & (US$ Million)
    Table 66. Lonza Recent Development
    Table 67. Boehringer ‎Ingelheim Company Details
    Table 68. Boehringer ‎Ingelheim Business Overview
    Table 69. Boehringer ‎Ingelheim Bio Contract Development and Manufacturing Organizations (CDMOs) Product
    Table 70. Boehringer ‎Ingelheim Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021) & (US$ Million)
    Table 71. Boehringer ‎Ingelheim Recent Development
    Table 72. Celltrion Company Details
    Table 73. Celltrion Business Overview
    Table 74. Celltrion Bio Contract Development and Manufacturing Organizations (CDMOs) Product
    Table 75. Celltrion Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021) & (US$ Million)
    Table 76. Celltrion Recent Development
    Table 77. Fujifilm Company Details
    Table 78. Fujifilm Business Overview
    Table 79. Fujifilm Bio Contract Development and Manufacturing Organizations (CDMOs) Product
    Table 80. Fujifilm Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021) & (US$ Million)
    Table 81. Fujifilm Recent Development
    Table 82. Selexis Company Details
    Table 83. Selexis Business Overview
    Table 84. Selexis Bio Contract Development and Manufacturing Organizations (CDMOs) Product
    Table 85. Selexis Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021) & (US$ Million)
    Table 86. Selexis Recent Development
    Table 87. Ology Bio Company Details
    Table 88. Ology Bio Business Overview
    Table 89. Ology Bio Bio Contract Development and Manufacturing Organizations (CDMOs) Product
    Table 90. Ology Bio Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021) & (US$ Million)
    Table 91. Ology Bio Recent Development
    Table 92. Ardena Company Details
    Table 93. Ardena Business Overview
    Table 94. Ardena Bio Contract Development and Manufacturing Organizations (CDMOs) Product
    Table 95. Ardena Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021) & (US$ Million)
    Table 96. Ardena Recent Development
    Table 97. Catalent Company Details
    Table 98. Catalent Business Overview
    Table 99. Catalent Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021) & (US$ Million)
    Table 100. Catalent Recent Development
    Table 101. AGC Company Details
    Table 102. AGC Business Overview
    Table 103. AGC Bio Contract Development and Manufacturing Organizations (CDMOs) Product
    Table 104. AGC Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021) & (US$ Million)
    Table 105. AGC Recent Development
    Table 106. Amgen Company Details
    Table 107. Amgen Business Overview
    Table 108. Amgen Bio Contract Development and Manufacturing Organizations (CDMOs) Product
    Table 109. Amgen Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021) & (US$ Million)
    Table 110. Amgen Recent Development
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Type: 2020 VS 2027
    Figure 2. API Development Features
    Figure 3. Manufacturing Features
    Figure 4. Drug Delivery Features
    Figure 5. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Application: 2020 VS 2027
    Figure 6. Pharmaceutical Company Case Studies
    Figure 7. Biotechnology Company Case Studies
    Figure 8. Generic Company Case Studies
    Figure 9. Bio Contract Development and Manufacturing Organizations (CDMOs) Report Years Considered
    Figure 10. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Regions: 2020 VS 2027
    Figure 13. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Regions (2022-2027)
    Figure 14. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Players in 2020
    Figure 15. Global Top Bio Contract Development and Manufacturing Organizations (CDMOs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue in 2020
    Figure 17. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Type (2016-2021)
    Figure 18. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Type (2022-2027)
    Figure 19. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Type (2016-2027)
    Figure 21. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Application (2016-2027)
    Figure 22. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Country (2016-2027)
    Figure 23. United States Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Type (2016-2027)
    Figure 27. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Application (2016-2027)
    Figure 28. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Country (2016-2027)
    Figure 29. Germany Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Region (2016-2027)
    Figure 39. China Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Type (2016-2027)
    Figure 47. Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Application (2016-2027)
    Figure 48. Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Country (2016-2027)
    Figure 49. Mexico Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Country (2016-2027)
    Figure 55. Turkey Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Lonza Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
    Figure 59. Boehringer ‎Ingelheim Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
    Figure 60. Celltrion Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
    Figure 61. Fujifilm Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
    Figure 62. Selexis Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
    Figure 63. Ology Bio Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
    Figure 64. Ardena Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
    Figure 65. Catalent Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
    Figure 66. AGC Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
    Figure 67. Amgen Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Lonza
Boehringer ‎Ingelheim
Celltrion
Fujifilm
Selexis
Ology Bio
Ardena
Catalent
AGC
Amgen
Frequently Asked Questions
Bio Contract Development and Manufacturing Organizations (CDMOs) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Bio Contract Development and Manufacturing Organizations (CDMOs) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Bio Contract Development and Manufacturing Organizations (CDMOs) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Maritime Logistics

Traditionally, Maritime Logistics was defined as a means of transporting parts and manufactured g ... Read More